On the public citation graph
Sotalol, but not digoxin is associated with decreased prostate cancer risk: A population‐based case–control study
0 signed · 42 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/pros.22733openalex-snapshot
Is digoxin use for cardiovascular disease associated with risk of prostate cancer?
inferredcites →https://doi.org/10.1007/s10549-011-1505-3openalex-snapshot
Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort
inferredcites →https://doi.org/10.1007/s10552-011-9819-3openalex-snapshot
The association between antihypertensive drug use and incidence of prostate cancer in Finland: a population-based case–control study
inferredcites →https://doi.org/10.1016/j.ejca.2006.12.001openalex-snapshot
Prostate cancer risk among users of finasteride and alpha-blockers – A population based case–control study
inferredcites →https://doi.org/10.1016/j.juro.2010.06.093openalex-snapshot
Cardiac Glycosides Decrease Prostate Specific Antigen Expression by Down-Regulation of Prostate Derived Ets Factor
inferredcites →https://doi.org/10.1016/s0022-5347(05)65724-2openalex-snapshot
INHIBITORY EFFECTS OF DIGITALIS ON THE PROLIFERATION OF ANDROGEN DEPENDENT AND INDEPENDENT PROSTATE CANCER CELLS
inferredcites →https://doi.org/10.1038/onc.2009.25openalex-snapshot
Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry
inferredcites →https://doi.org/10.1074/jbc.m403664200openalex-snapshot
Involvement of Cdk5/p25 in Digoxin-triggered Prostate Cancer Cell Apoptosis
inferredcites →https://doi.org/10.1093/aje/kwn190openalex-snapshot
Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study
inferredcites →https://doi.org/10.1111/j.1752-8062.2011.00376.xopenalex-snapshot
Digoxin Inhibits Blood Vessel Density and HIF‐1a Expression in Castration‐Resistant C4‐2 Xenograft Prostate Tumors
inferredcites →https://doi.org/10.1126/science.1236361openalex-snapshot
Autonomic Nerve Development Contributes to Prostate Cancer Progression
inferredcites →https://doi.org/10.1158/1055-9965.epi-07-0599openalex-snapshot
Cholesterol-Lowering Drugs and Prostate Cancer Risk: A Population-based Case-Control Study
inferredcites →https://doi.org/10.1158/1078-0432.ccr-11-1389openalex-snapshot
Molecular Pathways: Digoxin Use and Estrogen-Sensitive Cancers—Risks and Possible Therapeutic Implications
inferredcites →https://doi.org/10.1158/2159-8274.cd-10-0020openalex-snapshot
A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer Treatment
inferredcites →https://doi.org/10.1200/jco.2012.43.9190openalex-snapshot
Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study
inferredcites →https://doi.org/10.1254/jphs.08208scopenalex-snapshot
Malignancy Grade–Dependent Expression of K+-Channel Subtypes in Human Prostate Cancer
inferredcites →https://doi.org/10.3109/02841869409098430openalex-snapshot
Data Quality and Quality Control of a Population-Based Cancer Registry: Experience in Finland
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.3897/pharmacia.72.e143676zenodo-depositor-declared
Investigation of the promising repurposed, computational, and anticancer candidates to co-deliver with cabazitaxel for hormonal-resistance prostate cancer
inferred← citeshttps://doi.org/10.1002/bco2.441openalex-snapshot
Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
inferred← citeshttps://doi.org/10.1002/slct.201800486openalex-snapshot
Synthesis, Characterization and In Vitro Antitumor Activity of Glucosyl Ester Derivatives Containing Amino Acid Linker
inferred← citeshttps://doi.org/10.1007/978-3-319-64940-5_3openalex-snapshot
Consequence of Energy Imbalance in Prostate Cancer and Comorbidities
inferred← citeshttps://doi.org/10.1007/s10552-015-0693-2openalex-snapshot
Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial
inferred← citeshttps://doi.org/10.1007/s11696-018-0614-4openalex-snapshot
Enzymic synthesis, physicochemical, and cell activity of glucosyl ester derivatives based on N-fatty acyl amino acid
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.12283-8openalex-snapshot
Drug Repurposing Review
inferred← citeshttps://doi.org/10.1016/j.euf.2018.04.001openalex-snapshot
Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology
inferred← citeshttps://doi.org/10.1016/j.mattod.2024.11.006openalex-snapshot
Receptor agonist/antagonist-incorporated anticancer nanodrugs: Design, materials, and strategies
inferred← citeshttps://doi.org/10.1016/j.urolonc.2020.03.024openalex-snapshot
Use of beta-blocker types and risk of incident prostate cancer in a multiethnic population
inferred← citeshttps://doi.org/10.1038/bjc.2016.328openalex-snapshot
Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer
inferred← citeshttps://doi.org/10.1038/s41525-021-00216-6openalex-snapshot
Genome-wide discovery of hidden genes mediating known drug-disease association using KDDANet
inferred← citeshttps://doi.org/10.1038/s41598-018-28541-4openalex-snapshot
Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men
inferred← citeshttps://doi.org/10.1080/10253890.2016.1203415openalex-snapshot
Stress, catecholaminergic system and cancer
inferred← citeshttps://doi.org/10.1097/ppo.0000000000000362openalex-snapshot
Repurposed Drugs for Prostate Cancer
inferred← citeshttps://doi.org/10.1101/749762openalex-snapshot
Genome-wide discovery of hidden genes mediating known drug-disease association using KDDANet
inferred← citeshttps://doi.org/10.1111/and.14217openalex-snapshot
Digoxin reduces the incidence of prostate cancer but increases the cancer‐specific mortality: A systematic review and pooled analysis
inferred← citeshttps://doi.org/10.1111/bcp.13851openalex-snapshot
Using human experience to identify drug repurposing opportunities: theory and practice
inferred← citeshttps://doi.org/10.1159/000529969openalex-snapshot
Association between Resting Heart Rate and Oncological Outcomes in Patients with Early-Stage Cervical Cancer Who Have Undergone Radical Hysterectomy with Pelvic Lymphadenectomy
inferred← citeshttps://doi.org/10.1371/journal.pone.0178611openalex-snapshot
Cardiac glycosides use and the risk and mortality of cancer; systematic review and meta-analysis of observational studies
inferred← citeshttps://doi.org/10.3389/fimmu.2018.00164openalex-snapshot
Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response
inferred← citeshttps://doi.org/10.3389/fphar.2021.564097openalex-snapshot
Association Between Digoxin Use and Cancer Incidence: A Propensity Score-Matched Cohort Study With Competing Risk Analysis
inferred← citeshttps://doi.org/10.3389/fphar.2024.1423502openalex-snapshot
β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers
inferred← citeshttps://doi.org/10.4103/aja.aja_26_17openalex-snapshot
Antiarrhythmic drug usage and prostate cancer: a population-based cohort study
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.